Enterome
Team & Investors
Leadership, board of directors, and investment partners
Executives
0
Board Members
0
Investors
16
Total Funding
$292.3M
Investors
16 investors across all rounds
BS
Bristol-Myers Squibb
D
Danone
I(
INRAE (France)
IF
Institute for Follicular Lymphoma Innovation
LL
Leukemia & Lymphoma Society
Explore More Data
Detailed analysis for Enterome
Enterome Leadership & Investors
Enterome is led by a team of experienced leaders. The company has attracted investment from 16 institutional and strategic investors.
Who Has Invested in Enterome?
Enterome has raised $292.3M from 16 investors including venture capital firms, private equity investors, and strategic partners.
Investment Opportunity
Accredited investors can access Enterome shares through secondary market platforms like Premier Alternatives, joining the company's existing institutional investor base.